This episode takes a deep dive into Tesamorelin, a synthetic peptide that stimulates growth hormone release and has been FDA approved for reducing visceral fat in patients with HIV-associated lipodystrophy. Listeners will learn how Tesamorelin works, its effects on growth hormone and IGF-1, and why it stands out compared to other peptides. The discussion explores its impact on body composition, metabolic health, and liver fat, as well as potential off-label uses in obesity, fatty liver disease, and anti-aging research. Side effects, safety considerations, and long-term questions are also covered, giving you a balanced and accessible understanding of this unique peptide therapy.